Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction

American Heart Journal

Volumn 154, Issue 6, 2007, Pages 1052-1058

  Knowles, Joshua W ^a,b,c   Wang, Huijan ^a,b,c   Itakura, Haruka ^a,b,c   Southwick, Audrey ^a,b,c   Myers, Richard M ^a,b,c   Iribarren, Carlos ^a,b,c   Fortmann, Stephen P ^a,b,c   Go, Alan S ^a,b,c   Quertermous, Thomas ^a,b,c   Hlatky, Mark A ^a,b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CD36 GENE; CONTROLLED STUDY; CORONARY RISK; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; HEMOSTASIS; HUMAN; ITGB3 GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STABLE ANGINA PECTORIS; THBD GENE; THROMBOCYTE;

ANGINA PECTORIS; BLOOD COAGULATION FACTORS; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 36148988056     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.05.021     Document Type: Article

References (48)

1. Ye Z., Liu E.H.C., Higgins J.P.T., et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 367 (2006) 651-658
2. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107 (2003) 1117-1122
3. Boekholdt S.M., Bijsterveld N.R., Moons A.H.M., et al. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction. A systematic review. Circulation 104 (2001) 3063-3068
4. Ott I., Koch W., von Beckerath N., et al. Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction. Atherosclerosis 177 (2004) 189-191
5. Mälarstig A., Tenno T., Johnston N., et al. Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arterioscler Thromb Vasc Biol 25 (2005) 2667-2672
6. Ridker P.M., Baker M.T., Hennekens C.H., et al. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. Arterioscler Thromb Vasc Biol 17 (1997) 1687-1690
7. Wu A.H.B., and Tsongalis G.J. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 87 (2001) 1361-1366
8. Chao T.H., Li Y.H., Chen J.H., et al. Relation of thrombomodulin gene polymorphisms to acute myocardial infarction in patients ≤50 years of age. Am J Cardiol 93 (2004) 204-207
9. Wu K.K., Aleksic N., Ahn C., et al. Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease. Circulation 103 (2001) 1386-1389
10. Go A.S., Iribarren C., Chandra M., et al. Statin and β-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med 144 (2006) 229-238
11. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
12. Selby J.V., Ray G.T., Zhang D., et al. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 9 (1997) 1396-1402
13. Tabor H.K., Risch N.J., and Myers R.M. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 3 (2002) 391-397
14. A2 and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol 88 (2001) 347-352
15. Walter D.H., Schächinger V., Elsner M., et al. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 350 (1997) 1217-1219
16. 2807TT) with premature myocardial infarction. J Thromb Haemost 3 (2005) 1522-1529
17. Norlund L., Holm J., Zoller B., et al. A common thrombomodulin amino acid dimorphism is associated with myocardial infarction. Thromb Haemost 77 (1997) 248-251
18. Febbraio M., Hajjar D.P., and Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108 (2001) 785-791
19. Yamashita S., Hirano K., Kuwasako T., et al. Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. Mol Cell Biochem 299 (2007) 19-22
20. Endemann G., Stanton L.W., Madden K.S., et al. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268 (1993) 11811-11816
21. Abumrad N.A., el-Maghrabi M.R., Amri E.Z., et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268 (1993) 17665-17668
22. Guy E., Kuchibhotla S., Silverstein R., et al. Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36 degrees/apoE degrees mice. Atherosclerosis 192 (2007) 123-130
23. Moore K.J., Kunjathoor V.V., Koehn S.L., et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 115 (2005) 2192-2201
24. Kashiwagi H., Honda S., Tomiyama Y., et al. A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV deficiency. Thromb Haemost 69 (1993) 481-484
25. Weiss E.J., Bray P.F., Tayback M., et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334 (1996) 1090-1094
26. Zhu M.M., Weedon J., and Clark L.T. Meta-analysis of the association of platelet glycoprotein IIIa PIA1/A2 polymorphism with myocardial infarction. Am J Cardiol 86 (2000) 1000-1005
27. Auro K., Komulainen M., Alanne M., et al. Thrombomodulin gene polymorphisms and haplotypes and the risk of cardiovascular events. A prospective follow-up study. Arterioscler Thromb Vasc Biol 26 (2006) 942-947
28. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916-1923
29. Ireland H., Kunz G., Kyriakoulis K., et al. Thrombomodulin gene mutations associated with myocardial infarction. Circulation 96 (1997) 15-18
30. Morgan T.M., Krumholz H.M., Lifton R.P., et al. Nonvalidaton of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 297 (2007) 1551-1561
31. IIb gene. Br J Haematol 102 (1998) 622-625
32. Reiner A.P., Schwartz S.M., Kumar P.N., et al. Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women. Br J Haematol 112 (2001) 632-636
33. Hato T., Minamoto Y., Fukuyama T., et al. Polymorphisms of HPA-1 through 6 on platelet membrane glycoprotein receptors are not a genetic risk factor for myocardial infarction in the Japanese population. Am J Cardiol 80 (1997) 1222-1224
34. Bottiger C., Kastrati A., Koch W., et al. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 83 (2000) 559-562
35. Antoniades C., Tousoulis D., Vasiliadou C., et al. Genetic polymorphisms of platelet glycoprotein Ia and the risk for premature myocardial infarction. Effects on the release of sCD40L during the acute phase of premature myocardial infarction. J Am Coll Cardiol 47 (2006) 1959-1966
36. Leone A.M., De Stefano V., Burzotta F., et al. Glycoprotein Ia C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up. Heart 90 (2004) 567-569
37. Moshfegh K., Wuillemin W.A., Redondo M., et al. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 353 (1999) 351-354
38. 1 is associated with increased risk of cardiovascular mortality in high-risk women. Circulation 102 (2000) 1645-1650
39. Kakko S., Elo T., Tapanainen J.M., et al. Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest 32 (2002) 643-648
40. 1 polymorphisms: gene frequencies and linkage disequilibrium in a population diversity panel. J Thromb Haemost 3 (2005) 1511-1521
41. McCarthy J.J., Parker A., Salem R., et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 41 (2004) 334-341
42. Campo G., Valgimigli M., Ferraresi P., et al. Tissue factor and coagulation factor VII levels during acute myocardial infarction. Association with genotype and adverse events. Arterioscler Thromb Vasc Biol 26 (2006) 2800-2806
43. Arnaud E., Barbalat V., Nicaud V., et al. Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism. The ECTIM and PATHROS studies. Arterioscler Thromb Vasc Biol 20 (2000) 892-898
44. Ladenvall P., Johansson L., Jansson J.H., et al. Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarction. Thromb Haemost 87 (2002) 105-109
45. Jood K., Ladenvall P., Tjarnlund-Wolf A., et al. Fibrinolytic gene polymorphism and ischemic stroke. Stroke 36 (2005) 2077-2081
46. van der Bom J.G., de Knijff P., Haverkate F., et al. Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. Circulation 95 (1997) 2623-2627
47. Steeds R., Adams M., Smith P., et al. Distribution of tissue plasminogen activator insertion/deletion polymorphism in myocardial infarction and control subjects. Thromb Haemost 79 (1998) 980-984
48. Hooper W.C., Lally C., Austin H., et al. The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res 99 (2000) 223-230